Genetic Targeting Chemotherapy Treatment Breakthrough Sets Envita Apart
Envita Medical Centers is one of the leading integrative medical centers in the U.S. and abroad. The company was founded over 10 years ago and today Envita is comprised of a pioneering group of international doctors.
(prHWY.com) March 2, 2012 - Scottsdale Az, AZ -- Envita Medical Centers is one of the leading integrative medical centers in the U.S. and abroad. The company was founded over 10 years ago and today Envita is comprised of a pioneering group of international doctors. Envita offers unique, innovative, and personalized treatment for cancer and other chronic diseases.

Envita offers an expansive range of services to help cancer and chronic disease patients improve their clinical outcomes and enhance their quality and length of life. Envita has developed a clinically unique and targeted method for assisting cancer patients with customized chemotherapy options.

By working with numerous cancer patients that did not respond long-term to chemotherapy Treatments provided by traditional institutions, Envita began to profile the patients' tumors both molecularly and genetic ally, discovering that anywhere from 50-75 percent of their treatments were based upon ineffective treatment protocols or chemotherapy regimens. Such errors often result in highly toxic doses to the patients' immune system and healthy tissues using inefficacious chemotherapy drugs.

Envita's method incorporates proper genetic testing followed by the delivery of fractionated low doses. Another key aspect to Envita's strategy is the recognition that cancer cells use sugar as a primary energy source and therefore, express greater concentrations of insulin receptor sites. This example of targeting continues to allow patients to receive the maximum reward of proper treatment with minimum side effects. Clinically we have found this method to provide better results to our patients.

The current chemotherapy model used to treat cancer in cancer centers and hospitals is known as "germ theory" which focuses on destroying foreign cancer cells like an infection, by using an aggressive chemo regimen. And unlike its peers, Envita Medical Centers seek to combine chemotherapy treatment with properly targeted immunotherapy, as immunity begets long-term quality of life and positive outcomes.

To learn more, visit Envita.com or call 602-569-4144.

Contact Midea Information

Company Name: Envita Medical Centers of America
Contact Name: Rebekah Kanighan
Address : 8759 E. Bell Road. Bldg G. Scottsdale Az-85260 USA.
Contact No : 602-569-4144
fax No : 602-569-4244
Email ID : info@envita.com
Website : http://www.envita.com/

###

Web Site: http://www.envita.com/